EUDA Health Holdings Ltd

Aktienanalyse zu EUDA Health Holdings Ltd (EUDA)

$13.870

-0.889 (-6.41%)Zum Schluss

Loading chart…
Hoch
16.009
Eröffnung
15.350
Volumengewichteter Durchschnittskurs
14.46
Volumen
28.84K
Marktkap.
146.48M
Tief
13.510
Umsatz
417.13K
EV/EBITDA, TTM
0.00

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.

KI-Analyse of EUDA Health Holdings Ltd (EUDA)

Kaufen

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

Bewertungskennzahlen

Das aktuelle erwartete KGV von EUDA Health Holdings Ltd (EUDA) beträgt 7.81, verglichen mit dem 5-Jahres-Durchschnitt von -6.75.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
-6.75
Aktuelles P/E
7.81
Überbewertet
21.27
Unterbewertet
-34.77

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-4.08
Aktuelles EV/EBITDA
0.00
Überbewertet
1.31
Unterbewertet
-9.47

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
6.69
Aktuelles P/S
0.00
Überbewertet
12.36
Unterbewertet
1.03

Event-Zeitleiste

2026-07-30 (ET)

08:00:00

EUDA Health Signs MOU with GO POSB to Advance Cell Therapy

2026-07-28 (ET)

06:30:00

EUDA Health Signs Tripartite MOU with GO POSB for Next-Gen Therapies

2026-07-14 (ET)

10:30:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

2026-05-06 (ET)

09:40:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility Trading Pause

2026-04-29 (ET)

10:00:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

News

EUDA FAQ – beantwortet von Alphio AI

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required. It operates in the Industrials sector (SERVICES-HEALTH SERVICES industry).

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln